Sunday, June 26, 2022

Investing in Generation Bio Co. (GBIO): What You Must Know

Generation Bio Co.’s recently made public that its Director Nicholson Donald William acquired Company’s shares for reported $38273.0 on Mar 10. In the deal valued at $4.71 per share,8,126 shares were bought. As a result of this transaction, Nicholson Donald William now holds 113,576 shares worth roughly $ 0.76 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Then, Nicholson Donald William bought 2,293 shares, generating $10,983 in total proceeds. Upon buying the shares at $4.79, the Director now owns 105,450 shares.

Before that, Rhodes Jason P sold 16,586 shares. Generation Bio Co. shares valued at $407,850 were divested by the Director at a price of $24.59 per share. As a result of the transaction, Rhodes Jason P now holds 0 shares, worth roughly $0.0.

Taking this into account, William Blair downgraded its Generation Bio Co. [GBIO] rating to a Mkt perform from a an Outperform in a research note published on Tuesday. A number of analysts have revised their coverage, including JMP Securities’s analysts, who began to cover the stock in early June with a ‘”a Mkt outperform”‘ rating. William Blair began covering GBIO with a “an Outperform” recommendation on February 24, 2021. Needham started covering the stock on February 18, 2021. It rated GBIO as “a Buy”.

Price Performance Review of GBIO

On Tuesday, Generation Bio Co. [NASDAQ:GBIO] saw its stock jump 10.02% to $6.70. On the same session, the stock had its day’s lowest price of $6.23, but rose to a high of $7.13. Over the last five days, the stock has gained 24.07%. Generation Bio Co. shares have fallen nearly -5.37% since the year began. Nevertheless, the stocks have fallen -73.19% over the past one year. While a 52-week high of $28.67 was reached on 04/13/22, a 52-week low of $3.96 was recorded on 02/24/22. SMA at 50 days reached $6.29, while 200 days put it at $11.62. A total of 0.77 million shares were traded, compared to the trading of 0.68 million shares in the previous session.

Levels Of Support And Resistance For GBIO Stock

The 24-hour chart illustrates a support level at 6.24, which if violated will result in even more drops to 5.79. On the upside, there is a resistance level at 7.14. A further resistance level may holdings at 7.59. The Relative Strength Index (RSI) on the 14-day chart is 59.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.57%. Stochastics %K at 70.23% indicates the stock is a holding.

Generation Bio Co. [GBIO] – Who Are The Largest Shareholders?

In filings from T. Rowe Price Associates, Inc., it is revealed that the company now owns 8,763,691 shares, or roughly 15.36% of the outstanding GBIO shares. In other words, the investor’s shares have risen by 116,570 from its previous 13-F filing of 8647121.0. Additionally, Fidelity Management & Research Co increased 2.40% of its stake after which the total value it holdings stand at $47,581,573, while Bellevue Asset Management AG reduced -4.91% of its stake to hold $20.69 million in the firm. Over the last quarter, Farallon Capital Management LLC sold 0 shares of Generation Bio Co., while The Vanguard Group, Inc. sold -38,399 shares. At present, BlackRock Fund Advisors is holding 2,831,895 shares valued at $15.92 million. Invus Public Equities Advisors LL owned 2,814,191 shares of the company at the time of its most recent 13F filing, worth $15.82 million.

According to FactSet, Generation Bio Co.’s share price will average $20.20 in the next year, based on opinions of analysts polled by the firm. This is up nearly 294.09 percent from its previous closing price of $6.09. Analysts expect Generation Bio Co. stock to reach the higher price of $29.00, while the lowest price estimate is $10.00. However, 7 analysts have rated GBIO stock as an Overweight in their predictions for 2022. The most recent change occurred on July 07, 2020 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $31 price target.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam